Using a mobile app to help manage uncontrolled type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a mobile web application designed to educate patients with uncontrolled type 2 diabetes and assist them in making sustainable lifestyle changes. Participants will be divided into two groups: one using the app for educational content on diabetes management, while the other continues with standard care without the app. The study aims to assess the app's impact on clinical outcomes, such as HbA1c levels, and educational outcomes, including self-efficacy in diabetes management. The trial will also monitor changes in cardiometabolic risk factors like BMI and blood pressure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of Type 2 Diabetes with HA1c \>8.0
* Current patients of the Family Healthcare Center, Reading Hospital Tower health.

Exclusion Criteria:

* Identified special populations (pregnancy or individuals currently incarcerated)
* Patients without access to their own smart phone
* Any patient who is unable to provide their own informed consent to participate in the study

Where it's running

• Reading Hospital, an affiliate of Tower Health
  West Reading, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Luis A Murillo, MD, MPH — Reading Hospital Tower Health
• Study coordinator: Mary E Alderfer, MSN
• Email: mary.alderfer@towerhealth.org
• Phone: 484-628-8360

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proliverenol for liver fat and insulin resistance in type 2 diabetes

  This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.

  Recruiting Phase 2 Universitas Sriwijaya · Palembang, South Sumatera · NCT07928661

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes

  This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.

  Recruiting Phase 1 Novo Nordisk A/S · Neuss · NCT07896109

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin

  This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).

  Recruiting at 8 sites Phase 3 Amgen · San Diego, California and 7 other locations · NCT07866066

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.